close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Canada to Restrict Internet Pharmacy Sales to the United States

June 27, 2005

Canada to Restrict Internet Pharmacy Sales to the United States

Canadian Health Minister Ujjal Dosanjh is expected to announce restrictions this week on Canada-based Internet pharmacies that ship inexpensive drugs to people in the United States. Dosanjh calls the practice immoral and claims he is concerned that the industry, which brings into Canada approximately US$700 million per year, may cause a drug shortage in Canada.

The high cost of prescription medications in the US has prompted many people, particularly senior citizens, to seek alternative sources to fill their prescriptions. Unlike the US government, the Canadian government sets limits on the prices pharmaceutical firms may charge for drugs. In recent years, Americans have crossed the border into Canada, or gone online, to access Canada's less expensive medications.

Canada-based Internet pharmacies work like this, according to the Associated Press: "A prescription from a U.S. doctor is faxed to a Canadian doctor, who reviews the document along with the patient's health history. The Canadian doctor signs and sends the prescription to a so-called Internet pharmacy, which ships the drug to the patient. Canadian officials say such sales endanger the Canadian drug supply, though they admit no shortages currently exist. The government also maintains it is unethical for doctors to sign prescriptions without examining patients."

Potential Restrictions

Health Minister Dosanjh is reportedly "still struggling to find a way to clamp down on Internet pharmacies exporting cheap drugs to the US without shutting down the industry," according to the Winnipeg Sun (14 June). Although this suggests Dosanjh will permit the industry some measure of continued operation, entirely shutting down the industry remains an option. In this case, many believe that the Canadian Internet pharmacy industry, which is primarily based in Manitoba, would simply move to another country.

Other options Dosanjh may consider are to bar Canadian doctors from co-signing prescriptions without physically examining the patient; to prohibit sales to foreigners who are not in Canada; to ban bulk drug exports; and to prohibit price reductions on drugs sent out of the country, according to spokesperson Ken Polk.

The US Congress is currently considering several bills that would permit US residents to import drugs from other countries. However, US pharmaceutical companies have lashed back, threatening to stop drug shipments into Canada if the drugs are simply sent back to the US at cheaper prices.

Dosanjh is expected to make his announcement during or after the Canadian cabinet meeting this week.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...